Strategy
Cannabis Business Strategy in Europe
Strategy in this industry is mostly a series of narrowing decisions: which market, which segment, which model, which channel — and what you will deliberately not do.
Business model development
The same product can be sold as bulk ingredient, white-label supply, an owned brand or a licence. Those are four different businesses with different capital needs, margins and risk profiles. Choose consciously rather than by default.
Market positioning
In a regulated category, positioning is constrained by what you may say. The strongest positions are built on verifiable attributes — origin, quality system, consistency, supply reliability, service — rather than on effect claims.
Competitive analysis
Look at who already holds the shelf and the licence, not only at who has the most visible brand. In most European markets the decisive competitor is an incumbent distributor relationship.
Market selection and sequencing
Sequencing matters more than ambition. A smaller market that validates the model cheaply is usually worth more than a large market that consumes the budget before it teaches you anything.
Partnerships
Partner structure defines your economics: exclusivity terms, minimum volumes, marketing obligations, IP handling and exit conditions. Most disputes we see were written into the first agreement.
Go-to-market and scaling
Define the first hundred customers, the channel that reaches them, the price that holds after intermediaries, and the operational capacity you need to serve them without failing on delivery.
- Defined target customer and buying process
- Price architecture that survives the channel margin
- Realistic supply and lead times
- Clear kill criteria and review points
Need a second opinion on the business model?
Bring the plan you have. We will tell you where the margin actually sits and what will break first.